Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.

International journal of cancer - 1 Sept 2007

Moller Pal, Evans D Gareth, Reis Marta M, Gregory Helen, Anderson Elaine, Maehle Lovise, Lalloo Fiona, Howell Anthony, Apold Jaran, Clark Neal, Lucassen Anneke, Steel C Michael

Abstract excerpt

Women with a family history of breast cancer are commonly offered regular clinical or mammographic surveillance from age 30. Data on the efficacy of such programmes are limited. Clinical, pathological and outcome data were recorded on all breast and ovarian cancers diagnosed within familial breas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Mutation

Share to Population Surveillance

Share to Survival Rate

Share to Treatment Outcome

Source

Identifiers

PMID: 17471561
DOI: 10.1002/ijc.22789

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17471561-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.PMID 17471561Read ↗

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.Semantic proximity Read ↗

Outcomes of women at high familial risk for breast cancer: An 8-year single-center experience.Semantic proximity Read ↗

[Hereditary breast cancer].Semantic proximity Read ↗

Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.Semantic proximity Read ↗

BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in Norway.Semantic proximity Read ↗

Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer.Semantic proximity Read ↗

BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer.Semantic proximity Read ↗

Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.Semantic proximity Read ↗

BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories.Semantic proximity Read ↗

Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.Semantic proximity Read ↗

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status.Semantic proximity Read ↗

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.